PET and SPECT in low-grade glioma

被引:19
作者
Minn, H [1 ]
机构
[1] Turku Univ, Cent Hosp, Dept Radiotherapy & Oncol, Turku PET Ctr, FIN-20521 Turku, Finland
关键词
PET; SPECT; low-grade glioma; radionuclide imaging;
D O I
10.1016/j.ejrad.2005.03.020
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Low-grade gliomas (LGG) account for 30-40% of all gliomas and are primarily treated with surgery. Since both timing and use of other oncological treatments in LGG are a matter of controversy, there has been a constantly increasing demand to characterize these often slowly growing neoplasms with functional imaging methods, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT). PET and SPECT yield information on growth rate and heterogeneity of LGG and are especially useful in follow-up since metabolic changes tend to precede structural changes detected with structure-based imaging methods. Furthermore, for planning of LGG surgery or radiotherapy coregistration of functional images with CT and MRI is invaluable. This is increasingly performed with a new generation of hybrid scanners with integrated PET or SPECT and CT. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 54 条
[1]   Imaging gliomas with positron emission tomography and single-photon emission computed tomography [J].
Bénard, F ;
Romsa, J ;
Hustinx, R .
SEMINARS IN NUCLEAR MEDICINE, 2003, 33 (02) :148-162
[2]   Presurgical motor and somatosensory cortex mapping with functional magnetic resonance imaging and positron emission tomography [J].
Bittar, RG ;
Olivier, A ;
Sadikot, AF ;
Andermann, F ;
Pike, GB ;
Reutens, DC .
JOURNAL OF NEUROSURGERY, 1999, 91 (06) :915-921
[3]  
Blasberg RG, 2000, CANCER RES, V60, P624
[4]   Clinical role of positron emission tomography in oncology [J].
Bomanji, J. B. ;
Costa, D. C. ;
Ell, P. J. .
LANCET ONCOLOGY, 2001, 2 (03) :157-164
[5]   Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET [J].
Chung, JK ;
Kim, YK ;
Kim, SK ;
Lee, YJ ;
Paek, S ;
Yeo, JS ;
Jeong, JM ;
Lee, DS ;
Jung, HW ;
Lee, MC .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (02) :176-182
[6]   Positron emission tomography with injection of methionine as a prognostic factor in glioma [J].
De Witte, O ;
Goldberg, I ;
Wikler, D ;
Rorive, S ;
Damhaut, P ;
Monclus, M ;
Salmon, I ;
Brotchi, J ;
Goldman, S .
JOURNAL OF NEUROSURGERY, 2001, 95 (05) :746-750
[7]   Anatomical and biochemical investigation of primary brain tumours [J].
Del Sole, A ;
Falini, A ;
Ravasi, L ;
Ottobrini, L ;
De Marchis, D ;
Bombardieri, E ;
Lucignani, G .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (12) :1851-1872
[8]   The in vivo metabolic pattern of low-grade brain gliomas: A positron emission tomographic study using F-18-fluorodeoxyglucose and C-11-L-methylmethionine [J].
Derlon, JM ;
PetitTaboue, MC ;
Chapon, F ;
Beaudouin, V ;
Noel, MH ;
Creveuil, C ;
Courtheoux, P ;
Houtteville, JP .
NEUROSURGERY, 1997, 40 (02) :276-287
[9]   Prognostic value of positron emission tomography with [F-18]fluoro-2-deoxy-D-glucose in the low-grade glioma [J].
DeWitte, O ;
Levivier, M ;
Violon, P ;
Salmon, I ;
Damhaut, P ;
Wikler, D ;
Hildebrand, J ;
Brotchi, J ;
Goldman, S .
NEUROSURGERY, 1996, 39 (03) :470-476
[10]  
DICHIRO G, 1987, INVEST RADIOL, V22, P360